Mansour, L., M. Kotb, E. el Sobky, L. Tarek, W. Elnaggar, and M. Kamel, "Ataxia Telangiectasia: A Single Center Experience in a Decade", Pediatric Sciences Journal , vol. 2, issue 1, pp. 1-9, 2022. Ataxia Telangiectasia: A Single Center Experience in a Decade
FAROUK, M., S. Kaddah, and M. Kotb, "Anorectal Malformation: An Atypical Association of Pierre Robin Sequence", Pediatric Sciences Journal, vol. 2, issue 1, pp. 104-107, 2022. Anorectal Malformation: An Atypical Association of Pierre Robin Sequence
Basanti, C. W., M. A. Kotb, A. M. Sayed, M. Ghanem, and A. K. Abdelmegeid, "Nasopharyngeal Microbiome Composition is Different Among Children with Bronchial Asthma", Pediatric Sciences Journal, vol. 1, issue 2, pp. 77-88, 2021. Nasopharyngeal Microbiome Composition is Different Among Children with Bronchial Asthma
Eid, M. S., M. A. Kotb, S. Salah, and S. E. Z. Houchi, "Thyrotoxicosis Masquerading as Superior Mesenteric Artery Syndrome in An Adolescent", Pediatric Sciences Journal, vol. 3, issue 1, pp. 64-66, 2023.
Kotb, M. A., H. Abd El Baky, S. Sayed, M. A. Komy, M. Onsy, A. Aly, A. Tamer, and E. Mohamed, "Autosomal Recessive Polycystic Kidney Disease in a Child Complicated by Autoimmune Hemolytic Anemia: A Case Report", Pediatric Sciences Journal, vol. 3, issue 1, pp. 67-71, 2023.
Kotb, M. A., L. A. Fawaz, R. A. Zeitoun, Y. M. Shaalan, N. Aly, H. Abd El Kader, G. Eltagy, H. Esmat, A. F. Hamza, and H. Abd El Baky, "Bone demineralization in a cohort of Egyptian pediatric liver transplant recipients: Single center pilot study.", Medicine, vol. 101, issue 45, pp. e31156, 2022. Abstract

Liver transplantation (LT) is the definitive treatment of end-stage liver disease. The long-term survival following LT spurred more interest in improving the quality of life of patients. This was a cohort study that included 23 pediatric liver transplant recipients who underwent LT due to hereditary or metabolic liver diseases. Bone health assessment was performed at their last follow up clinically (anthropometric measures), biochemically and radiologically (Dual Energy X-ray Absorptiometry [DEXA] scans). Poor bone health was defined as z-score <-1. Mean age at LT was 5.77 years (standard deviation [SD] 3.64) and 43% were males. Biliary atresia was the most common cause of end stage liver disease (35%). Mean age at follow up was 14 years (SD 5.48) and mean follow up was 8 years (SD 4.12 years). Eleven patients (48%) had poor bone health (osteopenia 22% and osteoporosis 26%). On univariate analysis, being on steroids at last follow up (odds ratio [OR] 13.2, 95% confidence interval [CI] 1.23-140.67, P = .03), weight at last follow up (OR 0.45, 95% CI 0.20-0.99, P = .04), platelets at last follow up (OR 0.98, 95% CI 0.96-s0.99, P = .02), hemoglobin at last follow up (OR 0.33, 95% CI 0.12-0.89, P = .03) were significantly associated with poor bone health. None of the variables were significant on multivariate analysis. At most recent follow up, 48% of patients demonstrated poor bone health by DEXA scans. More studies are required to evaluate predictors of poor bone health after LT in children.

Kotb, M. A., A. Kotb, S. Talaat, S. M. Shehata, N. El Dessouki, A. A. ElHaddad, G. Eltagy, H. Esmat, S. Shehata, M. Hashim, et al., "Congenital aflatoxicosis, mal-detoxification genomics & ontogeny trigger immune-mediated Kotb disease biliary atresia variant: SANRA compliant review.", Medicine, vol. 101, issue 39, pp. e30368, 2022. Abstract

Biliary atresia (BA) is the most common indication for pediatric liver transplantation. We describe The BA variant: Kotb disease. Liver tissue in the Kotb disease BA is massively damaged by congenital aflatoxicosis resulting in inflammation, adhesions, fibrosis, bile duct proliferation, scarring, cholestasis, focal syncytial giant cell transformation, and typical immune response involving infiltration by CD4+, CD8+, CD68+, CD14+, neutrophil infiltration, neutrophil elastase spill, heavy loads of aflatoxin B1, accelerated cirrhosis, disruption of p53 and GSTPi, and have null glutathione S transferase M1 (GSTM1). All their mothers are heterozygous for GSTM1. This inability to detoxify aflatoxicosis results in progressive inflammatory adhesions and obliterative cholangiopathy early in life. The typical disruption of both p53 and GSTPi causes loss of fidelity of hepatic regeneration. Hence, regeneration in Kotb disease BA typically promotes accelerated cirrhosis. The immune response in Kotb disease BA is for damage control and initiation of regeneration, yet, this friendly fire incurs massive structural collateral damage. The Kotb disease BA is about actual ongoing hepatic entrapment of aflatoxins with lack of ability of safe disposal due to child detoxification-genomics disarray. The Kotb disease BA is a product of the interaction of persistent congenital aflatoxicosis, genetic lack of GSTM1 detoxification, ontogenically impaired activity of other hepatic detoxification, massive neutrophil-elastase, immune-induced damage, and disturbed regeneration. Ante-natal and neonatal screening for aflatoxicosis, avoiding cord milking, and stringent control of aflatoxicosis content of human, poultry and live-stock feeds might prove effective for prevention, prompt diagnosis and management based on our recent understanding of its patho-genomics.